Biological Stratification of Human Neuroblastoma by Complex "B" Pathway Ganglioside Expression

Cancer Research

Volumn 63, Issue 21, 2003, Pages 7270-7276

  Hettmer, Simone ^a   Malott, Carolin ^a   Woods, William ^b   Ladisch, Stephan ^a   Kaucic, Karen ^a,c  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b EMORY UNIVERSITY   (United States)

^c CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; FERRITIN; GANGLIOSIDE; GANGLIOSIDE GD 1B; GANGLIOSIDE GQ 1B; GANGLIOSIDE GT 1B; MYCN PROTEIN; NEURON SPECIFIC ENOLASE; PROTEIN; TUMOR MARKER; UNCLASSIFIED DRUG;

ANEUPLOIDY; ARTICLE; CANCER MORTALITY; CANCER RECURRENCE; CANCER SURVIVAL; EVENT FREE SURVIVAL; GANGLIOSIDE METABOLISM; HIGH RISK POPULATION; HUMAN; NEUROBLASTOMA; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; THIN LAYER CHROMATOGRAPHY;

CARBOHYDRATE SEQUENCE; COHORT STUDIES; GANGLIOSIDES; HUMANS; INFANT; MOLECULAR SEQUENCE DATA; NEOPLASM STAGING; NEUROBLASTOMA; PROGNOSIS; RISK FACTORS;

EID: 0242694910     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Hakomori, S. Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism. Cancer Res., 56: 5309-5318, 1996.
2. Schengrund, C. L., Repman, M. A., and Shochat, S. J. Ganglioside composition of human neuroblastomas. Correlation with prognosis. A Pediatric Oncology Group Study. Cancer (Phila.), 56: 2640-2646, 1985.
3. Schengrund, C. L., and Shochat, S. J. Gangliosides in neuroblastomas. Neurochem. Pathol., 8: 189-202, 1988.
4. Valentino, L., Moss, T., Olson, E., Wang, H. J., Elashoff, R., and Ladisch, S. Shed tumor gangliosides and progression of human neuroblastoma. Blood, 75: 1564-1567, 1990.
5. Kaucic, K., Etue, N., LaFleur, B., Woods, W., and Ladisch, S. Neuroblastomas of infancy exhibit a characteristic ganglioside pattern. Cancer (Phila.). 91: 785-793. 2001.
6. Ledeen, R. W., and Yu, R. K. Gangliosides: structure, isolation, and analysis. Methods Enzymol., 83: 139-191, 1982.
7. Wu, Z. L., Schwartz, E., Seeger, R., and Ladisch, S. Expression of GD2 ganglioside by untreated primary human neuroblastomas. Cancer Res., 46: 440-443, 1986.
8. Li, R. X., and Ladisch, S. Shedding of human neuroblastoma gangliosides. Biochim. Biophys. Acta, 1083: 57-64, 1991.
9. Srinivas, L., and Colburn, N. H. Ganglioside changes induced by tumor promoters in promotable JB6 mouse epidermal cells: antagonism by an antipromoter. J. Natl. Cancer Inst., 68: 469-473, 1982.
10. Kanda, N., Nakai, K., and Watanabe, S. Gangliosides GD1b, GT1B, and GQ1b suppress the growth of human melanoma by inhibiting interleukin-8 production: the inhibition of adenylate cyclase. J. Investig. Dermatol., 117: 284-293, 2001.
11. Hynds, D. L., Summers, M., Van Brocklyn, J., O'Dorisio, M. S., and Yates, A. J. Gangliosides inhibit platelet-derived growth factor-stimulated growth, receptor phosphorylation, and dimerization in neuroblastoma SH-SY5Y cells. J. Neurochem., 65: 2251-2258, 1995.
12. Sung, C. C., Pearl, D. K., Coons, S. W., Scheithauer, B. W., Johnson, P. C., Zheng, M., and Yates, A. J. Correlation of ganglioside pattems of primary brain tumors with survival. Cancer (Phila.). 75: 851-859, 1995.
13. Yates, A. J., Franklin, T. K., McKinney, P., Collins, R., Comas, T., Boesel, C. P., and Pearl, D. K. Gangliosides and neutral glycolipids in ependymal, neuronal and primitive neuroectodermal tumors. J. Mol. Neurosci., 12: 111-121, 1999.
14. Comas, T. C., Tai, T., Kimmel, D., Scheithauer, B. W., Burger, P. C., Pearl, D. K., Jewell, S. D., and Yates, A. J. Immunohistochemical staining for ganglioside GD1b as a diagnostic and prognostic marker for primary human brain tumors. Neuro-oncol., 1: 261-267, 1999.
15. Woods, W., Gao, R., Shuster, J., Robinson, L., Bernstein, M., Weitzman, S., Bunin, G., Levy, I., Brossard, J., Dougherty, G., Tuchman, M., and Lemieux, B. Screening of infants and mortality due to neuroblastoma. N. Engl. J. Med., 346: 1041-1046, 2002.
16. Bonilla, M. A., and Cheung, N. K. Clinical progress in neuroblastoma. Cancer Investig., 12: 644-653, 1994.
17. Brodeur, G. M., Maris, J. M., Yamashiro, D. J., Hogarty, M. D., and White, P. S. Biology and genetics of human neuroblastomas. J. Pediatr. Hematol. Oncol., 19: 93-101, 1997.
18. Taylor, S. R., and Locker, J. A comparative analysis of nuclear DNA content and N-mye gene amplification in neuroblastoma. Cancer (Phila.). 65: 1360-1366, 1990.
19. Brodeur, G. M., Look, A. T., Shimada, H., Hamilton, V. M., Maris, J. M., Hann, H. W., Leclerc, J. M., Bernstein, M., Brisson, L. C., Brossard, J. Lemieux, B., Tuchman, M., and Woods, W. G. Biological aspects of neuroblastomas identified by mass screening in Quebec. Med. Pediatr. Oncol., 36: 157-159, 2001.
20. Ladisch, S., and Gillard, B. A solvent partition method for microscale ganglioside purification. Anal. Biochem., 146: 220-231, 1985.
21. Song, H. H. Analysis of correlated ROC areas in diagnostic testing. Biometrics., 53: 370-382, 1997.
22. Look, A. T., Hayes, F. A., Shuster, J. J., Douglass, E. C., Castleberry, R. P., Bowman, L. C., Smith, E. I., and Brodeur, G. M. Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a Pediatric Oncology Group study. J. Clin. Oncol., 9: 581-591, 1991.
23. Seeger, R. C., Brodeur, G. M., Sather, H., Dalton, A., Siegel, S. E., Wong, K. Y., and Hammond, D. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N. Engl. J. Med., 313: 1111-1116, 1985.
24. Wagener, R., Rohn, G., Schillinger, G., Schroder, R., Kobbe, B., and Ernestus, R. I. Ganglioside profiles in human gliomas: quantification by microbore high performance liquid chromatography and correlation to histomorphology and grading. Acta Neurochir (Wien), 141: 1339-1345, 1999.
25. Soulieres, D., Rousseau, A., Deschenes, J., Tremblay, M., Tardif, M., and Pelletier, G. Characterization of gangliosides in human uveal melanoma cells. Int. J. Cancer, 49: 498-503, 1991.
26. Cheung, N. K., Kushner, B. H., Cheung, I. Y., Kramer, K., Canete, A., Gerald, W., Bonilla, M. A., Finn, R., Yeh, S. J., and Larson, S. M. Anti-G(D2) antibody treatment of minimal residual stage 4 neuroblastoma diagnosed at more than I year of age. J. Clin. Oncol., 16: 3053-3060, 1998.
27. Ladisch, S., Kitada, S., and Hays, E. F. Gangliosides shed by tumor cells enhance tumor formation in mice. J. Clin. Investig., 79: 1879-1882, 1987.
28. Floutsis, G., Ulsh, L., and Ladisch, S. Immunosuppressive activity of human neuroblastoma tumor gangliosides. Int. J. Cancer, 43: 6-9, 1989.
29. Kanda, N., and Tamaki, K. Ganglioside GQ1b enhances 1g production by human PBMCs. J. Allergy Clin. Immunol., 102: 813-820, 1998.
30. Kanda, N., and Tamaki, K. Ganglioside GD1b supresses immunoglobulin production by human peripheral blood mononuclear cells. Exp. Hematol., 27: 1487-1493, 1999.
31. Kanda, N., and Tamaki, K. Ganglioside GT1b suppresses immunoglobulin production by human peripheral blood mononuclear cells. Immunology, 96: 628-633, 1999.
32. Kanda, N., and Watanabe, S. Gangliosides GD1b, GT1b, and GQ1b enhance IL-2 and IFN-γ production and suppress IL-4 and IL-5 production in phytohemagglutinin-stimulated human T cells. J. Immunol., 166: 72-80, 2001.
33. Fukumoto, S., Mutoh, T., Hasegawa, T., Miyazaki, H., Okada, M., Goto, G., Furukawa, K., and Urano, T. GD3 synthase gene expression in PC12 cells results in the continuous activation of TrkA and ERK1/2 and enhanced proliferation. J. Biol. Chem., 275: 5832-5838, 2000.
34. Nara, K., Watanabe, Y., Kawashima, I., Tai, T., Nagai, Y., and Sanai, Y. Acceptor substrate specificity of a cloned GD3 synthase that catalyzes the biosynthesis of both GD3 and GD1c/GT1a/GQ1b. Eur. J. Biochem., 238: 647-652, 1996.
35. Ruan, S., Raj, B. K., and Lloyd, K. O. Relationship of glycosyltransferases and mRNA levels to ganglioside expression in neuroblastoma and melanoma cells. J Neurochem. 72: 514-521, 1999.